Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target

S C Dixon1, B J Soriano, R M Lush

  • 1Clinical Pharmacokinetics Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Abstract

Insights

Programmed cell death (apoptosis) is crucial for eliminating abnormal cells and maintaining health. Manipulating apoptosis offers a promising new strategy for developing targeted cancer therapies.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Biology

Background:

  • Apoptosis, or programmed cell death, is a fundamental biological process essential for organismal survival.
  • It plays a critical role in development, differentiation, homeostasis, and eliminating damaged or abnormal cells.
  • Dysregulation of apoptosis contributes to diseases like cancer, characterized by an imbalance in cell proliferation and death.

Purpose of the Study:

  • To review the literature on the role of apoptosis in cancer development.
  • To explore the potential of inducing apoptosis as a cancer therapy strategy.

Main Methods:

  • A comprehensive MEDLINE search was conducted.
  • Included articles focused on key cellular processes and genetic control of apoptosis.
  • Literature review of basic science articles was performed.

Main Results:

  • Apoptosis is vital for discarding unwanted, damaged, and atypical cells, regulating development, differentiation, and homeostasis.
  • Cancer involves an imbalance between cell division and elimination.
  • Targeting apoptosis can influence neoplastic cell accumulation, offering a novel therapeutic approach.

Conclusions:

  • Apoptosis is a highly organized physiological mechanism for cell destruction and homeostasis.
  • Both activation and inhibition of apoptosis are tightly regulated processes.
  • Pharmacological manipulation of apoptosis represents a novel therapeutic target in oncology.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...